Executive Summary
S. Jordan Associates (SJA) is proficient identifying non-dilutive capital sources from Local, State (Cancer Prevention Research Institute of Texas - CPRIT) and Federally sponsored institutions (SBIR).
Leverage non-dilutive capital during early stages of development to reach critical milestones resulting in subsequent financing rounds priced at higher valuations.
Guide clients through the application process and work collaboratively to implement best practices leading to successful awards.
Achievements 2016-2021
- Secured $50M+ of awards from the Cancer Prevention Research Institute of Texas (CPRIT) resulting in the advancement of drug programs through pre / clinical studies
- SJA worked closely with a Chicago-based gene therapy company, Inomagen Therapeutics, securing a $3.67M NIH / SBIR Fast Track award funding the company through IND
